Global Enteral Nutrition Drug Supply, Demand and Key Producers, 2023-2029

January 2023 | 119 pages | ID: G0FFADFAC31EEN
GlobalInfoResearch

Abstracts

Enteral nutrition drugs, also known as enteral nutrition preparations, are a generic term for a variety of products used in clinical enteral nutrition support, whose nutritional composition mainly includes a balance of various proteins, amino acids, sugars, fats, vitamins, minerals, dietary fibre, etc. The raw materials are mainly derived from terrestrial animal and plant extracts.

This report studies the global Enteral Nutrition Drug demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for Enteral Nutrition Drug, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Enteral Nutrition Drug that contribute to its increasing demand across many markets.

The global Enteral Nutrition Drug market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

Highlights and key features of the study

Global Enteral Nutrition Drug total market, 2018-2029, (USD Million)

Global Enteral Nutrition Drug total market by region & country, CAGR, 2018-2029, (USD Million)

U.S. VS China: Enteral Nutrition Drug total market, key domestic companies and share, (USD Million)

Global Enteral Nutrition Drug revenue by player and market share 2018-2023, (USD Million)

Global Enteral Nutrition Drug total market by Type, CAGR, 2018-2029, (USD Million)

Global Enteral Nutrition Drug total market by Application, CAGR, 2018-2029, (USD Million)

This reports profiles major players in the global Enteral Nutrition Drug market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Hospira Inc, Fresenius Kabi, Danone, Knowmedical, Nestl?, B. Braun Melsungen AG, Abbott, Otsuka Pharmaceutical India Private Limited and NUTRICHEM DI?T + PHARMA GMBH, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Enteral Nutrition Drug market

Detailed Segmentation:

Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Enteral Nutrition Drug Market, By Region:

• United States
• China
• Europe
• Japan
• South Korea
• ASEAN
• India
• Rest of World

Global Enteral Nutrition Drug Market, Segmentation by Type

• Adults
• Children

Global Enteral Nutrition Drug Market, Segmentation by Application

• Hospitals
• Clinics
• Pharmaceutical Companies
• Others

Companies Profiled:

• Hospira Inc
• Fresenius Kabi
• Danone
• Knowmedical
• Nestl?
• B. Braun Melsungen AG
• Abbott
• Otsuka Pharmaceutical India Private Limited
• NUTRICHEM DI?T + PHARMA GMBH
• Delta Drugs
• Baxter
• Allergan
• Actavis Inc.
• Grifols, S.A.
• Vifor Pharma

Key Questions Answered

1. How big is the global Enteral Nutrition Drug market?

2. What is the demand of the global Enteral Nutrition Drug market?

3. What is the year over year growth of the global Enteral Nutrition Drug market?

4. What is the total value of the global Enteral Nutrition Drug market?

5. Who are the major players in the global Enteral Nutrition Drug market?

6. What are the growth factors driving the market demand?

Contents

1 SUPPLY SUMMARY

1.1 Enteral Nutrition Drug Introduction
1.2 World Enteral Nutrition Drug Market Size & Forecast (2018 & 2022 & 2029)
1.3 World Enteral Nutrition Drug Total Market by Region (by Headquarter Location)
  1.3.1 World Enteral Nutrition Drug Market Size by Region (2018-2029), (by Headquarter Location)
  1.3.2 United States Enteral Nutrition Drug Market Size (2018-2029)
  1.3.3 China Enteral Nutrition Drug Market Size (2018-2029)
  1.3.4 Europe Enteral Nutrition Drug Market Size (2018-2029)
  1.3.5 Japan Enteral Nutrition Drug Market Size (2018-2029)
  1.3.6 South Korea Enteral Nutrition Drug Market Size (2018-2029)
  1.3.7 ASEAN Enteral Nutrition Drug Market Size (2018-2029)
  1.3.8 India Enteral Nutrition Drug Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
  1.4.1 Enteral Nutrition Drug Market Drivers
  1.4.2 Factors Affecting Demand
  1.4.3 Enteral Nutrition Drug Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
  1.5.1 Influence of COVID-19
  1.5.2 Influence of Russia-Ukraine War

2 DEMAND SUMMARY

2.1 World Enteral Nutrition Drug Consumption Value (2018-2029)
2.2 World Enteral Nutrition Drug Consumption Value by Region
  2.2.1 World Enteral Nutrition Drug Consumption Value by Region (2018-2023)
  2.2.2 World Enteral Nutrition Drug Consumption Value Forecast by Region (2024-2029)
2.3 United States Enteral Nutrition Drug Consumption Value (2018-2029)
2.4 China Enteral Nutrition Drug Consumption Value (2018-2029)
2.5 Europe Enteral Nutrition Drug Consumption Value (2018-2029)
2.6 Japan Enteral Nutrition Drug Consumption Value (2018-2029)
2.7 South Korea Enteral Nutrition Drug Consumption Value (2018-2029)
2.8 ASEAN Enteral Nutrition Drug Consumption Value (2018-2029)
2.9 India Enteral Nutrition Drug Consumption Value (2018-2029)

3 WORLD ENTERAL NUTRITION DRUG COMPANIES COMPETITIVE ANALYSIS

3.1 World Enteral Nutrition Drug Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
  3.2.1 Global Enteral Nutrition Drug Industry Rank of Major Players
  3.2.2 Global Concentration Ratios (CR4) for Enteral Nutrition Drug in 2022
  3.2.3 Global Concentration Ratios (CR8) for Enteral Nutrition Drug in 2022
3.3 Enteral Nutrition Drug Company Evaluation Quadrant
3.4 Enteral Nutrition Drug Market: Overall Company Footprint Analysis
  3.4.1 Enteral Nutrition Drug Market: Region Footprint
  3.4.2 Enteral Nutrition Drug Market: Company Product Type Footprint
  3.4.3 Enteral Nutrition Drug Market: Company Product Application Footprint
3.5 Competitive Environment
  3.5.1 Historical Structure of the Industry
  3.5.2 Barriers of Market Entry
  3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity

4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)

4.1 United States VS China: Enteral Nutrition Drug Revenue Comparison (by Headquarter Location)
  4.1.1 United States VS China: Enteral Nutrition Drug Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
  4.1.2 United States VS China: Enteral Nutrition Drug Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: Enteral Nutrition Drug Consumption Value Comparison
  4.2.1 United States VS China: Enteral Nutrition Drug Consumption Value Comparison (2018 & 2022 & 2029)
  4.2.2 United States VS China: Enteral Nutrition Drug Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based Enteral Nutrition Drug Companies and Market Share, 2018-2023
  4.3.1 United States Based Enteral Nutrition Drug Companies, Headquarters (States, Country)
  4.3.2 United States Based Companies Enteral Nutrition Drug Revenue, (2018-2023)
4.4 China Based Companies Enteral Nutrition Drug Revenue and Market Share, 2018-2023
  4.4.1 China Based Enteral Nutrition Drug Companies, Company Headquarters (Province, Country)
  4.4.2 China Based Companies Enteral Nutrition Drug Revenue, (2018-2023)
4.5 Rest of World Based Enteral Nutrition Drug Companies and Market Share, 2018-2023
  4.5.1 Rest of World Based Enteral Nutrition Drug Companies, Headquarters (States, Country)
  4.5.2 Rest of World Based Companies Enteral Nutrition Drug Revenue, (2018-2023)

5 MARKET ANALYSIS BY TYPE

5.1 World Enteral Nutrition Drug Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
  5.2.1 Adults
  5.2.2 Children
5.3 Market Segment by Type
  5.3.1 World Enteral Nutrition Drug Market Size by Type (2018-2023)
  5.3.2 World Enteral Nutrition Drug Market Size by Type (2024-2029)
  5.3.3 World Enteral Nutrition Drug Market Size Market Share by Type (2018-2029)

6 MARKET ANALYSIS BY APPLICATION

6.1 World Enteral Nutrition Drug Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
  6.2.1 Hospitals
  6.2.2 Clinics
  6.2.3 Pharmaceutical Companies
  6.2.4 Others
  6.2.5 Others
6.3 Market Segment by Application
  6.3.1 World Enteral Nutrition Drug Market Size by Application (2018-2023)
  6.3.2 World Enteral Nutrition Drug Market Size by Application (2024-2029)
  6.3.3 World Enteral Nutrition Drug Market Size by Application (2018-2029)

7 COMPANY PROFILES

7.1 Hospira Inc
  7.1.1 Hospira Inc Details
  7.1.2 Hospira Inc Major Business
  7.1.3 Hospira Inc Enteral Nutrition Drug Product and Services
  7.1.4 Hospira Inc Enteral Nutrition Drug Revenue, Gross Margin and Market Share (2018-2023)
  7.1.5 Hospira Inc Recent Developments/Updates
  7.1.6 Hospira Inc Competitive Strengths & Weaknesses
7.2 Fresenius Kabi
  7.2.1 Fresenius Kabi Details
  7.2.2 Fresenius Kabi Major Business
  7.2.3 Fresenius Kabi Enteral Nutrition Drug Product and Services
  7.2.4 Fresenius Kabi Enteral Nutrition Drug Revenue, Gross Margin and Market Share (2018-2023)
  7.2.5 Fresenius Kabi Recent Developments/Updates
  7.2.6 Fresenius Kabi Competitive Strengths & Weaknesses
7.3 Danone
  7.3.1 Danone Details
  7.3.2 Danone Major Business
  7.3.3 Danone Enteral Nutrition Drug Product and Services
  7.3.4 Danone Enteral Nutrition Drug Revenue, Gross Margin and Market Share (2018-2023)
  7.3.5 Danone Recent Developments/Updates
  7.3.6 Danone Competitive Strengths & Weaknesses
7.4 Knowmedical
  7.4.1 Knowmedical Details
  7.4.2 Knowmedical Major Business
  7.4.3 Knowmedical Enteral Nutrition Drug Product and Services
  7.4.4 Knowmedical Enteral Nutrition Drug Revenue, Gross Margin and Market Share (2018-2023)
  7.4.5 Knowmedical Recent Developments/Updates
  7.4.6 Knowmedical Competitive Strengths & Weaknesses
7.5 Nestl?
  7.5.1 Nestl? Details
  7.5.2 Nestl? Major Business
  7.5.3 Nestl? Enteral Nutrition Drug Product and Services
  7.5.4 Nestl? Enteral Nutrition Drug Revenue, Gross Margin and Market Share (2018-2023)
  7.5.5 Nestl? Recent Developments/Updates
  7.5.6 Nestl? Competitive Strengths & Weaknesses
7.6 B. Braun Melsungen AG
  7.6.1 B. Braun Melsungen AG Details
  7.6.2 B. Braun Melsungen AG Major Business
  7.6.3 B. Braun Melsungen AG Enteral Nutrition Drug Product and Services
  7.6.4 B. Braun Melsungen AG Enteral Nutrition Drug Revenue, Gross Margin and Market Share (2018-2023)
  7.6.5 B. Braun Melsungen AG Recent Developments/Updates
  7.6.6 B. Braun Melsungen AG Competitive Strengths & Weaknesses
7.7 Abbott
  7.7.1 Abbott Details
  7.7.2 Abbott Major Business
  7.7.3 Abbott Enteral Nutrition Drug Product and Services
  7.7.4 Abbott Enteral Nutrition Drug Revenue, Gross Margin and Market Share (2018-2023)
  7.7.5 Abbott Recent Developments/Updates
  7.7.6 Abbott Competitive Strengths & Weaknesses
7.8 Otsuka Pharmaceutical India Private Limited
  7.8.1 Otsuka Pharmaceutical India Private Limited Details
  7.8.2 Otsuka Pharmaceutical India Private Limited Major Business
  7.8.3 Otsuka Pharmaceutical India Private Limited Enteral Nutrition Drug Product and Services
  7.8.4 Otsuka Pharmaceutical India Private Limited Enteral Nutrition Drug Revenue, Gross Margin and Market Share (2018-2023)
  7.8.5 Otsuka Pharmaceutical India Private Limited Recent Developments/Updates
  7.8.6 Otsuka Pharmaceutical India Private Limited Competitive Strengths & Weaknesses
7.9 NUTRICHEM DI?T + PHARMA GMBH
  7.9.1 NUTRICHEM DI?T + PHARMA GMBH Details
  7.9.2 NUTRICHEM DI?T + PHARMA GMBH Major Business
  7.9.3 NUTRICHEM DI?T + PHARMA GMBH Enteral Nutrition Drug Product and Services
  7.9.4 NUTRICHEM DI?T + PHARMA GMBH Enteral Nutrition Drug Revenue, Gross Margin and Market Share (2018-2023)
  7.9.5 NUTRICHEM DI?T + PHARMA GMBH Recent Developments/Updates
  7.9.6 NUTRICHEM DI?T + PHARMA GMBH Competitive Strengths & Weaknesses
7.10 Delta Drugs
  7.10.1 Delta Drugs Details
  7.10.2 Delta Drugs Major Business
  7.10.3 Delta Drugs Enteral Nutrition Drug Product and Services
  7.10.4 Delta Drugs Enteral Nutrition Drug Revenue, Gross Margin and Market Share (2018-2023)
  7.10.5 Delta Drugs Recent Developments/Updates
  7.10.6 Delta Drugs Competitive Strengths & Weaknesses
7.11 Baxter
  7.11.1 Baxter Details
  7.11.2 Baxter Major Business
  7.11.3 Baxter Enteral Nutrition Drug Product and Services
  7.11.4 Baxter Enteral Nutrition Drug Revenue, Gross Margin and Market Share (2018-2023)
  7.11.5 Baxter Recent Developments/Updates
  7.11.6 Baxter Competitive Strengths & Weaknesses
7.12 Allergan
  7.12.1 Allergan Details
  7.12.2 Allergan Major Business
  7.12.3 Allergan Enteral Nutrition Drug Product and Services
  7.12.4 Allergan Enteral Nutrition Drug Revenue, Gross Margin and Market Share (2018-2023)
  7.12.5 Allergan Recent Developments/Updates
  7.12.6 Allergan Competitive Strengths & Weaknesses
7.13 Actavis Inc.
  7.13.1 Actavis Inc. Details
  7.13.2 Actavis Inc. Major Business
  7.13.3 Actavis Inc. Enteral Nutrition Drug Product and Services
  7.13.4 Actavis Inc. Enteral Nutrition Drug Revenue, Gross Margin and Market Share (2018-2023)
  7.13.5 Actavis Inc. Recent Developments/Updates
  7.13.6 Actavis Inc. Competitive Strengths & Weaknesses
7.14 Grifols, S.A.
  7.14.1 Grifols, S.A. Details
  7.14.2 Grifols, S.A. Major Business
  7.14.3 Grifols, S.A. Enteral Nutrition Drug Product and Services
  7.14.4 Grifols, S.A. Enteral Nutrition Drug Revenue, Gross Margin and Market Share (2018-2023)
  7.14.5 Grifols, S.A. Recent Developments/Updates
  7.14.6 Grifols, S.A. Competitive Strengths & Weaknesses
7.15 Vifor Pharma
  7.15.1 Vifor Pharma Details
  7.15.2 Vifor Pharma Major Business
  7.15.3 Vifor Pharma Enteral Nutrition Drug Product and Services
  7.15.4 Vifor Pharma Enteral Nutrition Drug Revenue, Gross Margin and Market Share (2018-2023)
  7.15.5 Vifor Pharma Recent Developments/Updates
  7.15.6 Vifor Pharma Competitive Strengths & Weaknesses

8 INDUSTRY CHAIN ANALYSIS

8.1 Enteral Nutrition Drug Industry Chain
8.2 Enteral Nutrition Drug Upstream Analysis
8.3 Enteral Nutrition Drug Midstream Analysis
8.4 Enteral Nutrition Drug Downstream Analysis

9 RESEARCH FINDINGS AND CONCLUSION

10 APPENDIX

10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. World Enteral Nutrition Drug Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World Enteral Nutrition Drug Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World Enteral Nutrition Drug Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World Enteral Nutrition Drug Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World Enteral Nutrition Drug Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Enteral Nutrition Drug Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World Enteral Nutrition Drug Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World Enteral Nutrition Drug Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World Enteral Nutrition Drug Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key Enteral Nutrition Drug Players in 2022
Table 12. World Enteral Nutrition Drug Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global Enteral Nutrition Drug Company Evaluation Quadrant
Table 14. Head Office of Key Enteral Nutrition Drug Player
Table 15. Enteral Nutrition Drug Market: Company Product Type Footprint
Table 16. Enteral Nutrition Drug Market: Company Product Application Footprint
Table 17. Enteral Nutrition Drug Mergers & Acquisitions Activity
Table 18. United States VS China Enteral Nutrition Drug Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China Enteral Nutrition Drug Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based Enteral Nutrition Drug Companies, Headquarters (States, Country)
Table 21. United States Based Companies Enteral Nutrition Drug Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies Enteral Nutrition Drug Revenue Market Share (2018-2023)
Table 23. China Based Enteral Nutrition Drug Companies, Headquarters (Province, Country)
Table 24. China Based Companies Enteral Nutrition Drug Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies Enteral Nutrition Drug Revenue Market Share (2018-2023)
Table 26. Rest of World Based Enteral Nutrition Drug Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Enteral Nutrition Drug Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies Enteral Nutrition Drug Revenue Market Share (2018-2023)
Table 29. World Enteral Nutrition Drug Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World Enteral Nutrition Drug Market Size by Type (2018-2023) & (USD Million)
Table 31. World Enteral Nutrition Drug Market Size by Type (2024-2029) & (USD Million)
Table 32. World Enteral Nutrition Drug Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World Enteral Nutrition Drug Market Size by Application (2018-2023) & (USD Million)
Table 34. World Enteral Nutrition Drug Market Size by Application (2024-2029) & (USD Million)
Table 35. Hospira Inc Basic Information, Area Served and Competitors
Table 36. Hospira Inc Major Business
Table 37. Hospira Inc Enteral Nutrition Drug Product and Services
Table 38. Hospira Inc Enteral Nutrition Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. Hospira Inc Recent Developments/Updates
Table 40. Hospira Inc Competitive Strengths & Weaknesses
Table 41. Fresenius Kabi Basic Information, Area Served and Competitors
Table 42. Fresenius Kabi Major Business
Table 43. Fresenius Kabi Enteral Nutrition Drug Product and Services
Table 44. Fresenius Kabi Enteral Nutrition Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. Fresenius Kabi Recent Developments/Updates
Table 46. Fresenius Kabi Competitive Strengths & Weaknesses
Table 47. Danone Basic Information, Area Served and Competitors
Table 48. Danone Major Business
Table 49. Danone Enteral Nutrition Drug Product and Services
Table 50. Danone Enteral Nutrition Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. Danone Recent Developments/Updates
Table 52. Danone Competitive Strengths & Weaknesses
Table 53. Knowmedical Basic Information, Area Served and Competitors
Table 54. Knowmedical Major Business
Table 55. Knowmedical Enteral Nutrition Drug Product and Services
Table 56. Knowmedical Enteral Nutrition Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. Knowmedical Recent Developments/Updates
Table 58. Knowmedical Competitive Strengths & Weaknesses
Table 59. Nestl? Basic Information, Area Served and Competitors
Table 60. Nestl? Major Business
Table 61. Nestl? Enteral Nutrition Drug Product and Services
Table 62. Nestl? Enteral Nutrition Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. Nestl? Recent Developments/Updates
Table 64. Nestl? Competitive Strengths & Weaknesses
Table 65. B. Braun Melsungen AG Basic Information, Area Served and Competitors
Table 66. B. Braun Melsungen AG Major Business
Table 67. B. Braun Melsungen AG Enteral Nutrition Drug Product and Services
Table 68. B. Braun Melsungen AG Enteral Nutrition Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. B. Braun Melsungen AG Recent Developments/Updates
Table 70. B. Braun Melsungen AG Competitive Strengths & Weaknesses
Table 71. Abbott Basic Information, Area Served and Competitors
Table 72. Abbott Major Business
Table 73. Abbott Enteral Nutrition Drug Product and Services
Table 74. Abbott Enteral Nutrition Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 75. Abbott Recent Developments/Updates
Table 76. Abbott Competitive Strengths & Weaknesses
Table 77. Otsuka Pharmaceutical India Private Limited Basic Information, Area Served and Competitors
Table 78. Otsuka Pharmaceutical India Private Limited Major Business
Table 79. Otsuka Pharmaceutical India Private Limited Enteral Nutrition Drug Product and Services
Table 80. Otsuka Pharmaceutical India Private Limited Enteral Nutrition Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 81. Otsuka Pharmaceutical India Private Limited Recent Developments/Updates
Table 82. Otsuka Pharmaceutical India Private Limited Competitive Strengths & Weaknesses
Table 83. NUTRICHEM DI?T + PHARMA GMBH Basic Information, Area Served and Competitors
Table 84. NUTRICHEM DI?T + PHARMA GMBH Major Business
Table 85. NUTRICHEM DI?T + PHARMA GMBH Enteral Nutrition Drug Product and Services
Table 86. NUTRICHEM DI?T + PHARMA GMBH Enteral Nutrition Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 87. NUTRICHEM DI?T + PHARMA GMBH Recent Developments/Updates
Table 88. NUTRICHEM DI?T + PHARMA GMBH Competitive Strengths & Weaknesses
Table 89. Delta Drugs Basic Information, Area Served and Competitors
Table 90. Delta Drugs Major Business
Table 91. Delta Drugs Enteral Nutrition Drug Product and Services
Table 92. Delta Drugs Enteral Nutrition Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 93. Delta Drugs Recent Developments/Updates
Table 94. Delta Drugs Competitive Strengths & Weaknesses
Table 95. Baxter Basic Information, Area Served and Competitors
Table 96. Baxter Major Business
Table 97. Baxter Enteral Nutrition Drug Product and Services
Table 98. Baxter Enteral Nutrition Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 99. Baxter Recent Developments/Updates
Table 100. Baxter Competitive Strengths & Weaknesses
Table 101. Allergan Basic Information, Area Served and Competitors
Table 102. Allergan Major Business
Table 103. Allergan Enteral Nutrition Drug Product and Services
Table 104. Allergan Enteral Nutrition Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 105. Allergan Recent Developments/Updates
Table 106. Allergan Competitive Strengths & Weaknesses
Table 107. Actavis Inc. Basic Information, Area Served and Competitors
Table 108. Actavis Inc. Major Business
Table 109. Actavis Inc. Enteral Nutrition Drug Product and Services
Table 110. Actavis Inc. Enteral Nutrition Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 111. Actavis Inc. Recent Developments/Updates
Table 112. Actavis Inc. Competitive Strengths & Weaknesses
Table 113. Grifols, S.A. Basic Information, Area Served and Competitors
Table 114. Grifols, S.A. Major Business
Table 115. Grifols, S.A. Enteral Nutrition Drug Product and Services
Table 116. Grifols, S.A. Enteral Nutrition Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 117. Grifols, S.A. Recent Developments/Updates
Table 118. Vifor Pharma Basic Information, Area Served and Competitors
Table 119. Vifor Pharma Major Business
Table 120. Vifor Pharma Enteral Nutrition Drug Product and Services
Table 121. Vifor Pharma Enteral Nutrition Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 122. Global Key Players of Enteral Nutrition Drug Upstream (Raw Materials)
Table 123. Enteral Nutrition Drug Typical Customers

List Of Figures

LIST OF FIGURES

Figure 1. Enteral Nutrition Drug Picture
Figure 2. World Enteral Nutrition Drug Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Enteral Nutrition Drug Total Market Size (2018-2029) & (USD Million)
Figure 4. World Enteral Nutrition Drug Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World Enteral Nutrition Drug Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company Enteral Nutrition Drug Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company Enteral Nutrition Drug Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company Enteral Nutrition Drug Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company Enteral Nutrition Drug Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company Enteral Nutrition Drug Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company Enteral Nutrition Drug Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company Enteral Nutrition Drug Revenue (2018-2029) & (USD Million)
Figure 13. Enteral Nutrition Drug Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Enteral Nutrition Drug Consumption Value (2018-2029) & (USD Million)
Figure 16. World Enteral Nutrition Drug Consumption Value Market Share by Region (2018-2029)
Figure 17. United States Enteral Nutrition Drug Consumption Value (2018-2029) & (USD Million)
Figure 18. China Enteral Nutrition Drug Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Enteral Nutrition Drug Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan Enteral Nutrition Drug Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea Enteral Nutrition Drug Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN Enteral Nutrition Drug Consumption Value (2018-2029) & (USD Million)
Figure 23. India Enteral Nutrition Drug Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of Enteral Nutrition Drug by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for Enteral Nutrition Drug Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for Enteral Nutrition Drug Markets in 2022
Figure 27. United States VS China: Enteral Nutrition Drug Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Enteral Nutrition Drug Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World Enteral Nutrition Drug Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World Enteral Nutrition Drug Market Size Market Share by Type in 2022
Figure 31. Adults
Figure 32. Children
Figure 33. World Enteral Nutrition Drug Market Size Market Share by Type (2018-2029)
Figure 34. World Enteral Nutrition Drug Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 35. World Enteral Nutrition Drug Market Size Market Share by Application in 2022
Figure 36. Hospitals
Figure 37. Clinics
Figure 38. Pharmaceutical Companies
Figure 39. Others
Figure 40. Enteral Nutrition Drug Industrial Chain
Figure 41. Methodology
Figure 42. Research Process and Data Source